California State Teachers Retirement System increased its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,719,981 shares of the healthcare conglomerate’s stock after purchasing an additional 31,097 shares during the quarter. UnitedHealth Group makes up approximately 1.0% of California State Teachers Retirement System’s holdings, making the stock its 13th largest holding. California State Teachers Retirement System owned 0.18% of UnitedHealth Group worth $428,482,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Crewe Advisors LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $25,000. Pearl River Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $35,000. Ipswich Investment Management Co. Inc. purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $40,000. OLD Second National Bank of Aurora grew its holdings in UnitedHealth Group by 70.0% in the 4th quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock valued at $42,000 after buying an additional 70 shares during the period. Finally, Laurel Wealth Advisors LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $42,000. Hedge funds and other institutional investors own 86.68% of the company’s stock.
Several analysts have commented on UNH shares. Cleveland Research restated a “buy” rating on shares of UnitedHealth Group in a report on Friday, January 11th. Credit Suisse Group reaffirmed a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a research note on Friday, February 8th. Argus lifted their price objective on UnitedHealth Group from $285.00 to $295.00 and gave the company a “buy” rating in a research note on Monday, December 17th. Stephens assumed coverage on UnitedHealth Group in a research note on Monday, January 14th. They issued an “overweight” rating and a $287.00 price objective on the stock. Finally, Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 19th. Three research analysts have rated the stock with a hold rating and twenty have given a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and an average price target of $297.80.
NYSE UNH opened at $230.20 on Tuesday. The stock has a market capitalization of $225.89 billion, a PE ratio of 17.87, a PEG ratio of 1.20 and a beta of 0.79. UnitedHealth Group Inc has a 1-year low of $220.77 and a 1-year high of $287.94. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.64.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 15th. The healthcare conglomerate reported $3.28 earnings per share for the quarter, beating the consensus estimate of $3.20 by $0.08. The business had revenue of $58.42 billion for the quarter, compared to analyst estimates of $58.01 billion. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The company’s revenue was up 12.2% compared to the same quarter last year. During the same period in the previous year, the company posted $2.59 EPS. Sell-side analysts expect that UnitedHealth Group Inc will post 14.62 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 1.56%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 27.95%.
In related news, Director Gail R. Wilensky sold 2,930 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $253.39, for a total transaction of $742,432.70. Following the transaction, the director now directly owns 64,726 shares of the company’s stock, valued at approximately $16,400,921.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $257.32, for a total value of $1,286,600.00. Following the transaction, the director now directly owns 182,454 shares in the company, valued at $46,949,063.28. The disclosure for this sale can be found here. Insiders have sold a total of 32,930 shares of company stock worth $8,495,383 over the last three months. 0.87% of the stock is currently owned by corporate insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.